Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
retinol dehydrogenase 13 | 0.821 | 0.115 | 6.0E-14 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
dipeptidyl peptidase 7 | 0.839 | 0.269 | 4.0E-22 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
cardiotrophin 1 | 0.636 | 0.423 | 4.2E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
troponin T2, cardiac type | 0.601 | 0.423 | 2.0E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
solute carrier family 31 member 1 | 0.612 | 0.577 | 6.5E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
glycine amidinotransferase | 0.666 | 0.615 | 5.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
thromboxane A2 receptor | 0.597 | 0.654 | 1.3E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
fatty acid binding protein 3 | 0.585 | 0.692 | 0.44 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
keratin 18 | 0.530 | 0.692 | 0.73 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
arginase 2 | 0.569 | 0.731 | 1.8E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
autophagy related 7 | 0.505 | 0.769 | 7.4E-12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
poly(U) binding splicing factor 60 | 0.536 | 0.769 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
apoptosis inducing factor mitochondria associated 1 | 0.527 | 0.769 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
glyceraldehyde-3-phosphate dehydrogenase | 0.447 | 0.808 | 0.11 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
retinol binding protein 4 | 0.493 | 0.808 | 0.52 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
SET nuclear proto-oncogene | 0.507 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
superoxide dismutase 3 | 0.531 | 0.808 | 7.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
microRNA 192 | 0.503 | 0.846 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 |